Applied Spectral Imaging (ASI) is a Global Leader in Digital Cytogenetics and Pathology.
Founded in 1993, ASI has established a global presence across more than 80 countries. With over 5000 systems installed worldwide, the Company provides a comprehensive product portfolio in the field of biomedical imaging.
ASI's technology, powered by GenASIs, offers a broad range of solutions for brightfield, fluorescence and spectral imaging. Its multiple applications address diagnostic needs across several domains, including karyotyping, FISH, digital pathology and a combined "All-in-One" solution.
The Company's extensive portfolio of FDA-cleared products include BandView, FISHView, SpotScan for CEP XY, UroVysion, ALK, and HER2/neu FISH, as well as the HiPath immunohistochemistry (IHC) Family for HER2, ER, PR, and Ki67 in manual configuration. The ASI product family is IVDR compliant.
With offices in the USA and Asia, as well as a vast network of global distribution partners, ASI is dedicated to advancing diagnostic capabilities worldwide, because every diagnosis counts.
